Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Researchers describe atom-by-atom changes in ALS-linked protein

For the first time, researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone.

19 Jan 2018

New initiative seeks to transform the way people live with dementia

Challenge Dementia, supported by Nesta, launches today as the first national search for next generation products, technologies and services that could transform the way people live with dementia helping them to live enjoyable and fulfilling lives for as long as possible.

19 Jan 2018

Signaling molecules likely involved in concussions, rodent studies show

Traumatic brain injuries, whether suffered from a blow on the football field or the battle field, can be devastating, leading to disability and shortened lives.

18 Jan 2018

Neuronal loss is very limited in Alzheimer’s disease, shows new study

Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses.

17 Jan 2018

Study shows high-salt diet causes dementia in mice

A high-salt diet reduces resting blood flow to the brain and causes dementia in mice, according to a new study by scientists from Weill Cornell Medicine.

17 Jan 2018

Postcard from Sacramento: Alzheimer’s ‘looks like me, it looks like you’

Until last year, Jackie Coleman was a disability rights lawyer — a good one, too.

16 Jan 2018

Study reveals how devastating mitochondrial diseases strike families without any previous history

Researchers have shown for the first time how children can inherit a severe - potentially fatal - mitochondrial disease from a healthy mother.

15 Jan 2018

Mitochondrial impairment may actually protect the brain in Parkinson's disease, study shows

A Norwegian study shows that impairment in mitochondria may actually protect the brain in Parkinson's disease.

15 Jan 2018

Whole of Britain to be put on a diet plan come March

New Year resolutions have not been broken yet and Public Health England is coming up with a set of new guidelines for healthier eating. The entire country needs to watch calories and PHE is coming up with the “calorie caps” on all meals come March this year.

15 Jan 2018

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.

12 Jan 2018

Researchers use novel PET tracer to assess myelin damage in mouse models of MS

The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallmark of the immune-mediated neurological disorder multiple sclerosis.

12 Jan 2018

Study finds overall pattern of commonality between Huntington's and Parkinson's

A new study strongly suggests that the brains of people who have died of Huntington's disease (HD) and Parkinson's disease (PD) show a similar response to a lifetime of neurodegeneration, despite being two very distinct diseases.

12 Jan 2018

Worsening of anxiety symptoms may be early indicator of Alzheimer's disease

A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of Alzheimer's disease in older adults.

12 Jan 2018

Novel polygenic hazard score captures age variations of aggressive prostate cancer

An international team, led by researchers at the University of California San Diego School of Medicine, has developed and validated a genetic tool for predicting age of onset of aggressive prostate cancer, a disease that kills more than 26,000 American men annually.

12 Jan 2018

Insilico Medicine develops new deep-learning based hematological human aging clock

Today, Insilico Medicine, Inc., a Baltimore-based company specializing in the application of artificial intelligence for drug discovery, biomarker development and aging research, announced a publication of a research paper titled "Population-specific biomarkers of human aging: a big data study using South Korean, Canadian and Eastern-European patient populations" in The Journal of Gerontology.

11 Jan 2018

For elder health, trips to the ER are often a tipping point

Twice a day, the 86-year-old man went for long walks and visited with neighbors along the way. Then, one afternoon he fell while mowing his lawn. In the emergency room, doctors diagnosed a break in his upper arm and put him in a sling.

11 Jan 2018

Pfizer to stop Alzheimer’s and Parkinson’s disease research

Pharmaceutical giant Pfizer has announced its intention to stop research and development in areas including Alzheimer’s disease and Parkinson’s disease.

11 Jan 2018

Salk scientists identify molecular target of experimental Alzheimer’s drug

The experimental drug J147 is something of a modern elixir of life; it's been shown to treat Alzheimer's disease and reverse aging in mice and is almost ready for clinical trials in humans.

10 Jan 2018

Alzheimer’s Research UK calls on pharma to continue supporting dementia research

Alzheimer’s Research UK is calling for a recommitment from pharmaceutical companies to continue efforts to fund research into dementia, the leading cause of death in the UK.

10 Jan 2018

General anesthesia may be more complex in its workings than we know now

Associate Professor Bruno van Swinderen from Queensland Brain Institute, University of Queensland with his colleagues have studied the workings of general anesthetics on the brain and found that these agents did more than just put a person to sleep. These findings could pave the way for better and more effective anesthetics they believe. The study was published in the latest issue of the journal Cell Reports.

10 Jan 2018

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Researchers describe atom-by-atom changes in ALS-linked protein

New initiative seeks to transform the way people live with dementia

Signaling molecules likely involved in concussions, rodent studies show

Neuronal loss is very limited in Alzheimer’s disease, shows new study

Study shows high-salt diet causes dementia in mice

Postcard from Sacramento: Alzheimer’s ‘looks like me, it looks like you’

Study reveals how devastating mitochondrial diseases strike families without any previous history

Mitochondrial impairment may actually protect the brain in Parkinson's disease, study shows

Whole of Britain to be put on a diet plan come March

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

Researchers use novel PET tracer to assess myelin damage in mouse models of MS

Study finds overall pattern of commonality between Huntington's and Parkinson's

Worsening of anxiety symptoms may be early indicator of Alzheimer's disease

Novel polygenic hazard score captures age variations of aggressive prostate cancer

Insilico Medicine develops new deep-learning based hematological human aging clock

For elder health, trips to the ER are often a tipping point

Pfizer to stop Alzheimer’s and Parkinson’s disease research

Salk scientists identify molecular target of experimental Alzheimer’s drug

Alzheimer’s Research UK calls on pharma to continue supporting dementia research

General anesthesia may be more complex in its workings than we know now

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in